跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
hematopoietic stem cells
首页
药物
hematopoietic stem cells
hematopoietic stem cells
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF
EP 3844187 A1
申请人: VOR BIOPHARMA INC
优先权: 2018
CN
EP
US
WO
23 件公开
METHODS FOR GENERATING HEMATOPOIETIC STEM CELLS
EP 3802790 A4
申请人: BRIGHAM & WOMENS HOSPITAL INC
优先权: 2018
CN
EP
US
WO
9 件公开
EP 4072570 A4
申请人: BRIGHAM & WOMENS HOSPITAL INC
优先权: 2019
CN
EP
WO
4 件公开
ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
EP 3558389 A1
申请人: NOVARTIS AG
优先权: 2016
CN
EP
US
WO
8 件公开
CN 112437675 A
申请人: NOVARTIS AG
优先权: 2018
CN
METHODS OF GENERATING AND EXPANDING HEMATOPOIETIC STEM CELLS
EP 3976066 A4
申请人: CHILDRENS HOSPITAL MED CT
优先权: 2019
CN
EP
US
WO
6 件公开
DIFFERENTIATION OF PRIMATE PLURIPOTENT STEM CELLS TO HEMATOPOIETIC LINEAGE CELLS
EP 3293255 A1
申请人: ASTERIAS BIOTHERAPEUTICS INC
优先权: 2008
CN
EP
US
6 件公开
EXPANDING HEMATOPOIETIC STEM CELLS
EP 2643454 A4
申请人: GAO HONG
优先权: 2010
EP
US
5 件公开
VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS
EP 4323381 A1
申请人: MASSACHUSETTS INST TECHNOLOGY
优先权: 2021
CN
EP
US
WO
4 件公开
MODIFIED HEMATOPOIETIC STEM CELLS AND PROGENIES THEREOF
EP 4599055 A1
申请人: GARUDA THERAPEUTICS INC
优先权: 2022
CN
EP
US
WO
4 件公开
PD-L1 expressing hematopoietic stem cells and uses
US 10517899 B2
申请人: CHILDRENS MEDICAL CT CORP
优先权: 2015
CN
US
4 件公开
Methods for purifying hematopoietic stem cells
US 8088585 B2
申请人: BALAZS ALEJANDRO
优先权: 2004
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈